Diuretic activity, safety and pharmacokinetics of torasemide during chronic treatment in normal subjects View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1986-01

AUTHORS

Y. Ambroes, I. Ronflette, L. Dodion

ABSTRACT

Torasemide 40 mg/day p.o. was administered for 21 days to 8 healthy volunteers to investigate its pharmacodynamics, pharmacokinetics and safety on chronic administration. It induced a highly significant initial increase in 24-h urinary volume and 24-h excretion of sodium and chloride, but its affect diminished after the first days. On Days 0, 1, 10 and 21 the experiment was divided in 3 clearance phases, extending from 0 to 2 h, 2 to 6 h and 6 to 24 h after dosing. The fractional excretion of sodium, chloride, potassium, calcium, magnesium and inorganic phosphates peaked during the first 2 h and returned almost to the control value during the following two clearance phases. The phase-dependent changes were significant for all electrolytes, except for potassium and inorganic phosphate. Plasma electrolyte levels remained constant throughout the study, except for a small decrease in chloride and potassium and for an increase in calcium and magnesium. Fasting blood glucose and glucose tolerance test were unaffected. A small but significant decrease in LDL-cholesterol was observed on Day 10. Other plasma lipid components showed minor changes. Plasma uric acid levels were moderately increased. There was no significant change of the creatinine clearance. Body weight fell significantly (by about 2 kg) during the study. Tonal audiometry was normal before and after the study. There was no significant difference between the plasma levels of torasemide on Days 1, 10 and 21, nor between its elimination half-life on Days 1 and 21. Side-effects consisted mainly of fatigue and low-back pain on days of intense diuresis.(ABSTRACT TRUNCATED AT 250 WORDS) More... »

PAGES

1-7

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00541460

DOI

http://dx.doi.org/10.1007/bf00541460

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1003363483

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/3780835


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1116", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Physiology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calcium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diuretics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kinetics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Magnesium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Potassium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sodium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sulfonamides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Torsemide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Uric Acid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Urine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Saint Etienne Clinic, Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ambroes", 
        "givenName": "Y.", 
        "id": "sg:person.01242546465.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242546465.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Saint Etienne Clinic, Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ronflette", 
        "givenName": "I.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Medical Department A. Christiaens S.A., Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dodion", 
        "givenName": "L.", 
        "id": "sg:person.01356775065.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356775065.07"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf01747104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002452921", 
          "https://doi.org/10.1007/bf01747104"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01747104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002452921", 
          "https://doi.org/10.1007/bf01747104"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0026-0495(73)90264-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008746933"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm197104152841506", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010957021"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9149(79)80338-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011589858"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0021-9150(80)90204-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013813794"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00541465", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022122500", 
          "https://doi.org/10.1007/bf00541465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00541465", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022122500", 
          "https://doi.org/10.1007/bf00541465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00625798", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029985014", 
          "https://doi.org/10.1007/bf00625798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.3.5827.620", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031136057"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.1978.tb00837.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038315847"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(82)91506-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038590926"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.1980.03310150027023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044819086"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.280.6218.905", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048678221"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9343(69)90187-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050813268"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.244.15.1691", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054139508"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0028-1111261", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057126788"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0028-1113442", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057128956"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078454423", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082160355", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1986-01", 
    "datePublishedReg": "1986-01-01", 
    "description": "Torasemide 40 mg/day p.o. was administered for 21 days to 8 healthy volunteers to investigate its pharmacodynamics, pharmacokinetics and safety on chronic administration. It induced a highly significant initial increase in 24-h urinary volume and 24-h excretion of sodium and chloride, but its affect diminished after the first days. On Days 0, 1, 10 and 21 the experiment was divided in 3 clearance phases, extending from 0 to 2 h, 2 to 6 h and 6 to 24 h after dosing. The fractional excretion of sodium, chloride, potassium, calcium, magnesium and inorganic phosphates peaked during the first 2 h and returned almost to the control value during the following two clearance phases. The phase-dependent changes were significant for all electrolytes, except for potassium and inorganic phosphate. Plasma electrolyte levels remained constant throughout the study, except for a small decrease in chloride and potassium and for an increase in calcium and magnesium. Fasting blood glucose and glucose tolerance test were unaffected. A small but significant decrease in LDL-cholesterol was observed on Day 10. Other plasma lipid components showed minor changes. Plasma uric acid levels were moderately increased. There was no significant change of the creatinine clearance. Body weight fell significantly (by about 2 kg) during the study. Tonal audiometry was normal before and after the study. There was no significant difference between the plasma levels of torasemide on Days 1, 10 and 21, nor between its elimination half-life on Days 1 and 21. Side-effects consisted mainly of fatigue and low-back pain on days of intense diuresis.(ABSTRACT TRUNCATED AT 250 WORDS)", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf00541460", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054337", 
        "issn": [
          "0031-6970", 
          "1432-1041"
        ], 
        "name": "European Journal of Clinical Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "Suppl 1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "31"
      }
    ], 
    "name": "Diuretic activity, safety and pharmacokinetics of torasemide during chronic treatment in normal subjects", 
    "pagination": "1-7", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "1005a457b0f6b06a30eec6f67b2384f7351ab6df5091873f83037b63fc8b144c"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "3780835"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "1256165"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00541460"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1003363483"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00541460", 
      "https://app.dimensions.ai/details/publication/pub.1003363483"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130830_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/BF00541460"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00541460'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00541460'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00541460'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00541460'


 

This table displays all metadata directly associated to this object as RDF triples.

208 TRIPLES      21 PREDICATES      64 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00541460 schema:about N0b7452d26223474facaec6cce613c58f
2 N0c7c782e4a5549d483d047d974dc18ea
3 N0ccf99e50f6249fbbbd71dc221b3ee32
4 N154ec7d4db8b40f5a49e6f134576ccc9
5 N1a3f61a004cd4dba843ef62465e7bb4b
6 N1b0ebad6aea1457882e9d57565ef12dd
7 N27daf94c6e2048ba80da39d5c214c44a
8 N282132b3fd32408285acd1d7d3653fca
9 N54effc4e85ac4419a33294534991c556
10 N99daca8d6afe411d96b25c56672d57f4
11 N9da4bd5108ce4079ae1cd00d730ddb42
12 Na7fe8a1d5f1a4fdb815c92e9262005a4
13 Nc73d927336c84fc8bfc7566329b1af83
14 Nc9356af1631541fd838095f356857dac
15 Nd55636fa9ee440f5ace2536bb44ff5be
16 Nddcf183ca6d544ce97dee1708f76ec4f
17 Nfd757689864a48d7a46727f2af957cd7
18 anzsrc-for:11
19 anzsrc-for:1116
20 schema:author Nb4fe1e3b2dbe44bab8b997cb50249be6
21 schema:citation sg:pub.10.1007/bf00541465
22 sg:pub.10.1007/bf00625798
23 sg:pub.10.1007/bf01747104
24 https://app.dimensions.ai/details/publication/pub.1078454423
25 https://app.dimensions.ai/details/publication/pub.1082160355
26 https://doi.org/10.1001/jama.1980.03310150027023
27 https://doi.org/10.1001/jama.244.15.1691
28 https://doi.org/10.1016/0002-9343(69)90187-9
29 https://doi.org/10.1016/0021-9150(80)90204-x
30 https://doi.org/10.1016/0026-0495(73)90264-3
31 https://doi.org/10.1016/s0002-9149(79)80338-0
32 https://doi.org/10.1016/s0140-6736(82)91506-9
33 https://doi.org/10.1055/s-0028-1111261
34 https://doi.org/10.1055/s-0028-1113442
35 https://doi.org/10.1056/nejm197104152841506
36 https://doi.org/10.1111/j.1365-2125.1978.tb00837.x
37 https://doi.org/10.1136/bmj.280.6218.905
38 https://doi.org/10.1136/bmj.3.5827.620
39 schema:datePublished 1986-01
40 schema:datePublishedReg 1986-01-01
41 schema:description Torasemide 40 mg/day p.o. was administered for 21 days to 8 healthy volunteers to investigate its pharmacodynamics, pharmacokinetics and safety on chronic administration. It induced a highly significant initial increase in 24-h urinary volume and 24-h excretion of sodium and chloride, but its affect diminished after the first days. On Days 0, 1, 10 and 21 the experiment was divided in 3 clearance phases, extending from 0 to 2 h, 2 to 6 h and 6 to 24 h after dosing. The fractional excretion of sodium, chloride, potassium, calcium, magnesium and inorganic phosphates peaked during the first 2 h and returned almost to the control value during the following two clearance phases. The phase-dependent changes were significant for all electrolytes, except for potassium and inorganic phosphate. Plasma electrolyte levels remained constant throughout the study, except for a small decrease in chloride and potassium and for an increase in calcium and magnesium. Fasting blood glucose and glucose tolerance test were unaffected. A small but significant decrease in LDL-cholesterol was observed on Day 10. Other plasma lipid components showed minor changes. Plasma uric acid levels were moderately increased. There was no significant change of the creatinine clearance. Body weight fell significantly (by about 2 kg) during the study. Tonal audiometry was normal before and after the study. There was no significant difference between the plasma levels of torasemide on Days 1, 10 and 21, nor between its elimination half-life on Days 1 and 21. Side-effects consisted mainly of fatigue and low-back pain on days of intense diuresis.(ABSTRACT TRUNCATED AT 250 WORDS)
42 schema:genre research_article
43 schema:inLanguage en
44 schema:isAccessibleForFree false
45 schema:isPartOf N07bfa767276442019a4703696fcff443
46 N13e9340f2e524bc0a554976cf74da786
47 sg:journal.1054337
48 schema:name Diuretic activity, safety and pharmacokinetics of torasemide during chronic treatment in normal subjects
49 schema:pagination 1-7
50 schema:productId N53e175a215954eb892483c244e8d0845
51 N7713746eac19403fb894a7b9baa06fc6
52 N98cff66c06224611a7e424e3a64e13a7
53 Na1ad8266737247fa9088651fb8925acd
54 Na65bf3f4255c45fb94b1106e8438e21f
55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003363483
56 https://doi.org/10.1007/bf00541460
57 schema:sdDatePublished 2019-04-11T14:01
58 schema:sdLicense https://scigraph.springernature.com/explorer/license/
59 schema:sdPublisher N141b03cd34d2445d81268ae8f3672d2d
60 schema:url http://link.springer.com/10.1007/BF00541460
61 sgo:license sg:explorer/license/
62 sgo:sdDataset articles
63 rdf:type schema:ScholarlyArticle
64 N07bfa767276442019a4703696fcff443 schema:volumeNumber 31
65 rdf:type schema:PublicationVolume
66 N0b7452d26223474facaec6cce613c58f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Male
68 rdf:type schema:DefinedTerm
69 N0c7c782e4a5549d483d047d974dc18ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Sulfonamides
71 rdf:type schema:DefinedTerm
72 N0ccf99e50f6249fbbbd71dc221b3ee32 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Sodium
74 rdf:type schema:DefinedTerm
75 N13e9340f2e524bc0a554976cf74da786 schema:issueNumber Suppl 1
76 rdf:type schema:PublicationIssue
77 N141b03cd34d2445d81268ae8f3672d2d schema:name Springer Nature - SN SciGraph project
78 rdf:type schema:Organization
79 N154ec7d4db8b40f5a49e6f134576ccc9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Uric Acid
81 rdf:type schema:DefinedTerm
82 N1a3f61a004cd4dba843ef62465e7bb4b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Diuretics
84 rdf:type schema:DefinedTerm
85 N1b0ebad6aea1457882e9d57565ef12dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Humans
87 rdf:type schema:DefinedTerm
88 N27daf94c6e2048ba80da39d5c214c44a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Calcium
90 rdf:type schema:DefinedTerm
91 N282132b3fd32408285acd1d7d3653fca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Adult
93 rdf:type schema:DefinedTerm
94 N44106e0e78de441db45c5e4b2d678260 rdf:first sg:person.01356775065.07
95 rdf:rest rdf:nil
96 N4913297a82764d6c8729a9a2e7e3a21d schema:name Saint Etienne Clinic, Brussels, Belgium
97 rdf:type schema:Organization
98 N50aa2520d7674efab5a4cfa12df97a4a schema:name Saint Etienne Clinic, Brussels, Belgium
99 rdf:type schema:Organization
100 N53e175a215954eb892483c244e8d0845 schema:name pubmed_id
101 schema:value 3780835
102 rdf:type schema:PropertyValue
103 N54effc4e85ac4419a33294534991c556 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Kinetics
105 rdf:type schema:DefinedTerm
106 N64e263f0f2004a6493c142d8bf0e65ae schema:affiliation N50aa2520d7674efab5a4cfa12df97a4a
107 schema:familyName Ronflette
108 schema:givenName I.
109 rdf:type schema:Person
110 N7713746eac19403fb894a7b9baa06fc6 schema:name readcube_id
111 schema:value 1005a457b0f6b06a30eec6f67b2384f7351ab6df5091873f83037b63fc8b144c
112 rdf:type schema:PropertyValue
113 N98cff66c06224611a7e424e3a64e13a7 schema:name dimensions_id
114 schema:value pub.1003363483
115 rdf:type schema:PropertyValue
116 N99daca8d6afe411d96b25c56672d57f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Potassium
118 rdf:type schema:DefinedTerm
119 N9da4bd5108ce4079ae1cd00d730ddb42 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Time Factors
121 rdf:type schema:DefinedTerm
122 Na1ad8266737247fa9088651fb8925acd schema:name nlm_unique_id
123 schema:value 1256165
124 rdf:type schema:PropertyValue
125 Na65bf3f4255c45fb94b1106e8438e21f schema:name doi
126 schema:value 10.1007/bf00541460
127 rdf:type schema:PropertyValue
128 Na7fe8a1d5f1a4fdb815c92e9262005a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Blood Glucose
130 rdf:type schema:DefinedTerm
131 Nae825d45cf904efe9ad6ced11dbf728d schema:name Medical Department A. Christiaens S.A., Brussels, Belgium
132 rdf:type schema:Organization
133 Nb4fe1e3b2dbe44bab8b997cb50249be6 rdf:first sg:person.01242546465.34
134 rdf:rest Ne072b8447a9d47e18947f82e174d93f0
135 Nc73d927336c84fc8bfc7566329b1af83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Female
137 rdf:type schema:DefinedTerm
138 Nc9356af1631541fd838095f356857dac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Torsemide
140 rdf:type schema:DefinedTerm
141 Nd55636fa9ee440f5ace2536bb44ff5be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Lipids
143 rdf:type schema:DefinedTerm
144 Nddcf183ca6d544ce97dee1708f76ec4f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Urine
146 rdf:type schema:DefinedTerm
147 Ne072b8447a9d47e18947f82e174d93f0 rdf:first N64e263f0f2004a6493c142d8bf0e65ae
148 rdf:rest N44106e0e78de441db45c5e4b2d678260
149 Nfd757689864a48d7a46727f2af957cd7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Magnesium
151 rdf:type schema:DefinedTerm
152 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
153 schema:name Medical and Health Sciences
154 rdf:type schema:DefinedTerm
155 anzsrc-for:1116 schema:inDefinedTermSet anzsrc-for:
156 schema:name Medical Physiology
157 rdf:type schema:DefinedTerm
158 sg:journal.1054337 schema:issn 0031-6970
159 1432-1041
160 schema:name European Journal of Clinical Pharmacology
161 rdf:type schema:Periodical
162 sg:person.01242546465.34 schema:affiliation N4913297a82764d6c8729a9a2e7e3a21d
163 schema:familyName Ambroes
164 schema:givenName Y.
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242546465.34
166 rdf:type schema:Person
167 sg:person.01356775065.07 schema:affiliation Nae825d45cf904efe9ad6ced11dbf728d
168 schema:familyName Dodion
169 schema:givenName L.
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356775065.07
171 rdf:type schema:Person
172 sg:pub.10.1007/bf00541465 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022122500
173 https://doi.org/10.1007/bf00541465
174 rdf:type schema:CreativeWork
175 sg:pub.10.1007/bf00625798 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029985014
176 https://doi.org/10.1007/bf00625798
177 rdf:type schema:CreativeWork
178 sg:pub.10.1007/bf01747104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002452921
179 https://doi.org/10.1007/bf01747104
180 rdf:type schema:CreativeWork
181 https://app.dimensions.ai/details/publication/pub.1078454423 schema:CreativeWork
182 https://app.dimensions.ai/details/publication/pub.1082160355 schema:CreativeWork
183 https://doi.org/10.1001/jama.1980.03310150027023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044819086
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1001/jama.244.15.1691 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054139508
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1016/0002-9343(69)90187-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050813268
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1016/0021-9150(80)90204-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1013813794
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1016/0026-0495(73)90264-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008746933
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1016/s0002-9149(79)80338-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011589858
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1016/s0140-6736(82)91506-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038590926
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1055/s-0028-1111261 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057126788
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1055/s-0028-1113442 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057128956
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1056/nejm197104152841506 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010957021
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1111/j.1365-2125.1978.tb00837.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1038315847
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1136/bmj.280.6218.905 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048678221
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1136/bmj.3.5827.620 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031136057
208 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...